TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $233,436 | +31.7% | 15,521 | +3.6% | 0.09% | +22.9% |
| Q4 2022 | $177,284 | +99.2% | 14,986 | 0.0% | 0.07% | +75.0% |
| Q3 2022 | $89,000 | +39.1% | 14,986 | 0.0% | 0.04% | +48.1% |
| Q2 2022 | $64,000 | -55.2% | 14,986 | 0.0% | 0.03% | -43.8% |
| Q1 2022 | $143,000 | -30.9% | 14,986 | +141.2% | 0.05% | -26.2% |
| Q3 2021 | $207,000 | -14.1% | 6,214 | 0.0% | 0.06% | -13.3% |
| Q2 2021 | $241,000 | – | 6,214 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |